POS1165 Lifestyle And Mood Changes In Axspa Patients During The Quarantine Period
Authors: E. Erpek, D. Solmaz, E. Durak Ediboglu, G. Alp, E. Otman Akat, H. Cinakli, G. Kabadayi, İ. Kurut Aysin, O. Bayindir, S. Gucenmez, M. Ozmen, S. Akar
Journal: Annals of the Rheumatic Diseases (2021)

Background: On March 11, 2020, the World Health Organization declared coronavirus disease 2019 (COVID-19) as a pandemic, and mandatory quarantine was applied in Turkey between April and June 2020. With this sanction, sudden changes occurred in a routine lifestyle. Objectives: This study aimed at evaluating physical activity changes, presence of anxiety and depression, altered eating habits and their relationship with disease activity in axial spondyloarthritis (AxSpA) patients during the quarantine period. Methods: AxSpA patients, who were examined in the rheumatology clinic in the last year before the pandemic period and their relatives were included in this study and were contacted by phone to participate. A structured questionnaire form was performed which included the following data: questions about demographic characteristics, medication use, disease activity scales; BASDAI, BASFI, Patient acceptable symptom state (PASS), patient-reported physical activity state, Short Questionnaire to Assess Health enhancing physical activity (SQUASH), Three-Factor Eating Questionnaire (TFEQ-21), and Hospital Anxiety and Depression Scale (HADs). Results: 204 AxSpA patients and 106 patients’ relatives were contacted in the study (Figure 1). The frequency of male sex and alcohol consumption was higher in the AxSpA compared to the relatives and, other demographic features were summarized in Table 1. 30% of AxSpA patients and 37% of patient relatives were gained weight with mean 4.5±2.4 and 4.4±3.4 kilograms, respectively. Weight gain were similar male and female in AxSpA (26.2% vs 37.2%, p&gt;0.05). However, the men in the AxSpA group gained more weight than relatives group (26.2% vs 7%, p&lt;0.05). Weight gain group had decreased physical activity than stable group in AxSpA patients (54.8% vs 37.8%, p&lt;0.05). We showed mild negative correlation between BASDAI and BASFI scores with SQUASH- total activity score (r:-0.15, p&lt;0.05; r:-0.25, p&lt;0.001, respectively). Anxiety prevalence were found slightly higher in patients group but not significantly (40.2% vs 32.1%; p&gt;0.05). Depression were much higher in AxSpA group than relatives (43.6% vs 28%, p&lt;0.001). Depression and anxiety were correlated with disease activity (HADs Depression vs BASDAI r:0.380, p&lt;0.001; HADs Anxiety vs BASDAI r:0.418, p&lt;0.001) and function (HADs Depression vs BASFI r:0.342, p&lt;0.001; HADs Anxiety vs BASFI r:0.313, p&lt;0.001). Among eating habits, uncontrolled and emotional eating scores were showed low correlation with anxiety (r:0.169, p&lt;0.05; r:0.163, p&lt;0.05, respectively). Conclusion: One third of our patients were weight gain and approximately half of them had decreased physical activity but we did not show relation between these parameters and disease related factors in the limited period. In addition to that depression and anxiety were detected significant part of AxSpA patients and both of them were correlated with disease activity. Table 1. Study Population Characteristics AxSpa n:204 Controls n:106 p value Age (years) mean ± SD 43.1±11.4 40.6±12.6 &gt;0.05 Male n(%) 125(61.3) 26(24.5) &lt;0.001 Education time (years) mean ± SD 9.8±4.3 9.7±4.0 &gt;0.05 Current smoker n(%) 77(37.7) 31(29.2) &gt;0.05 Alcohol consumption n(%) 60(29.4) 9(8.5) &lt;0.001 Current BMI kg/m 2 mean ± SD 26.8±4.6 26.5±4.7 &gt;0.05 Weight gain group n(%) 62 (30.4) 40(37.7) &gt;0.05 Weight stable group n(%) 142 (69.6) 66(62.3) Current BASDAI mean ± SD 1.8±1.5 N/A Current BASFI mean ± SD 1.5±1.8 N/A Patients treated with biologic drugs n(%) 118(57.8) N/A Patients treated with conventional drugs n(%) 84(41.1) N/A Presence of Anxiety n(%) 82(40.2) 34(32.1) &gt;0.05 Presence of Depression n(%) 89(43.6) 30(28.0) &lt;0.001 TFEQ-R21emotional eating mean ± SD 5.2±3.1 5.6±2.7 &lt;0.05 TFEQ-R21uncontrolled eating mean ± SD 14.7±6.3 17.5±5.4 &lt;0.001 TFEQ-R21cognitive restraint mean ± SD 14.3±4.3 15±4.2 &gt;0.05 Stable physical activity n(%) 117(57.4) 49(46.2) &gt;0.05 Decreased physical activity n(%) 87(42.6) 57(53.8) Acknowledgements: Special thanks to our clinical nurse Alev Vayni for her devoted assistance in interviewing patients to fill out the questionaire. Disclosure of Interests: None declared.